Category:Katherine Pfeiffer of San Francisco CA (US)

Katherine Pfeiffer of San Francisco CA (US)

Executive Summary

Katherine Pfeiffer of San Francisco CA (US) is an inventor who has filed 4 patents. Their primary areas of innovation include In situ hybridisation (2 patents), using probe arrays or probe chips ( (2 patents), involving nucleic acid arrays, e.g. sequencing by hybridisation (2 patents), and they have worked with companies such as 10x Genomics, Inc. (3 patents), 10X GENOMICS, INC. (1 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C12Q1/6841 (In situ hybridisation): 2 patents
• C12Q1/6837 (using probe arrays or probe chips (): 2 patents
• C12Q1/6874 (involving nucleic acid arrays, e.g. sequencing by hybridisation): 2 patents
• G01N1/30 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms): 1 patents
• G01N33/532 (Immunoassay; Biospecific binding assay; Materials therefor): 1 patents
• C07K14/70539 (PEPTIDES (peptides in foodstuffs): 1 patents
• C12N15/1037 ({Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display}): 1 patents
• C12N15/1055 ({Protein x Protein interaction, e.g. two hybrid selection}): 1 patents
• C12N15/1065 ({Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}): 1 patents
• C12N15/1075 ({by coupling phenotype to genotype, not provided for in other groups of this subclass}): 1 patents
• C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 1 patents
• C12N15/85 (for animal cells): 1 patents
• C12Q1/6804 (Nucleic acid analysis using immunogens (immunoassay): 1 patents
• C12Q1/6806 (Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (): 1 patents
• C12Q1/6818 (involving interaction of two or more labels, e.g. resonant energy transfer): 1 patents
• C12Q1/6827 (for detection of mutation or polymorphism): 1 patents
• C12Q1/6881 (involving nucleic acids): 1 patents
• G01N33/5032 ({on intercellular interactions}): 1 patents
• G01N33/505 (Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes): 1 patents
• G01N33/5304 (Immunoassay; Biospecific binding assay; Materials therefor): 1 patents
• G01N33/5306 ({Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding}): 1 patents
• G01N33/5308 ({for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}): 1 patents
• G01N33/54306 ({Solid-phase reaction mechanisms}): 1 patents
• G01N33/54366 ({Apparatus specially adapted for solid-phase testing}): 1 patents
• G01N33/548 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms): 1 patents
• G01N33/56977 (for microorganisms, e.g. protozoa, bacteria, viruses): 1 patents
• G01N33/58 (involving labelled substances (): 1 patents
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/10 (in screening processes): 1 patents
• C12Q2537/164 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
• C12Q2563/179 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
• C12Q2563/185 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
• C12Q2565/1015 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
• C40B30/04 (COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides): 1 patents
• C12N15/1093 ({General methods of preparing gene libraries, not provided for in other subgroups}): 1 patents

Companies

List of Companies

• 10x Genomics, Inc.: 3 patents
• 10X GENOMICS, INC.: 1 patents

Collaborators

• Andrew Scott Kohlway of Dublin CA (US) (2 collaborations)
• Andrew John Hill of Seattle WA (US) (2 collaborations)
• Paul Eugene Lund of San Leandro CA (US) (2 collaborations)
• Jawad N. Abousoud of Pleasanton CA (US) (2 collaborations)
• Sharmila Chatterjee Bhattacharjee of San Jose CA (US) (2 collaborations)
• Ryan Stott of Oakland CA (US) (2 collaborations)
• Caroline Julie Gallant (1 collaborations)
• Marlon Stoeckius (1 collaborations)
• Stephane Boutet of Burlingame CA (US) (1 collaborations)